Baculoviral IAP Repeat-Containing 5 抗体
BIRC5 适用: 人, 小鼠 WB, ELISA, IHC (p), FACS, IF (cc), IF (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
BIRC5 适用: 人 WB, ELISA, IF, IP, RNAi 宿主: 小鼠 Monoclonal 5B10 unconjugated
Baculoviral IAP Repeat-Containing 5 抗体 by Grade
Find Baculoviral IAP Repeat-Containing 5 抗体 with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
Baculoviral IAP Repeat-Containing 5 抗体 by 适用
Find Baculoviral IAP Repeat-Containing 5 抗体 for a variety of species such as anti-Human Baculoviral IAP Repeat-Containing 5, anti-Mouse Baculoviral IAP Repeat-Containing 5, anti-Rat Baculoviral IAP Repeat-Containing 5. The species listed below are among those available. Click on a link to go to the corresponding products.
Baculoviral IAP Repeat-Containing 5 抗体 by 抗体来源
Find Baculoviral IAP Repeat-Containing 5 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
Baculoviral IAP Repeat-Containing 5 抗体 by 克隆形成能力
Find available monoclonal or polyclonal Baculoviral IAP Repeat-Containing 5 抗体. Click on a link to go to the corresponding products.
Popular Baculoviral IAP Repeat-Containing 5 抗体
- (1)
- (8)
- (2)
- (6)
- (2)
- (7)
- (7)
- (12)
- (7)
- (5)
- (4)
- (4)
- (3)
- (3)
- (2)
- (2)
- (4)
- (2)
- (2)
Latest Publications for our Baculoviral IAP Repeat-Containing 5 抗体
: "Canstatin represses glioma growth by inhibiting formation of VM-like structures." in: Translational neuroscience, Vol. 12, Issue 1, pp. 309-319, (2021) (PubMed).: "Inhibitory Effects of Indomethacin in Human MNNG/HOS Osteosarcoma Cell Line In Vitro." in: Cancer investigation, Vol. 38, Issue 1, pp. 23-36, (2020) (PubMed).
: "Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model." in: Cancer letters, Vol. 443, pp. 25-33, (2019) (PubMed).
: "Mitotic progression, arrest, exit or death relies on centromere structural integrity, rather than de novo transcription." in: eLife, Vol. 7, (2019) (PubMed).
: "Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma." in: International journal of molecular sciences, Vol. 19, Issue 9, (2019) (PubMed).
: "HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma." in: International journal of cancer, Vol. 142, Issue 9, pp. 1926-1937, (2019) (PubMed).
: "Biological effects of whole Z.Officinale extract on chronic myeloid leukemia cell line K562." in: Gene, Vol. 692, pp. 217-222, (2019) (PubMed).
: "CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells." in: International journal of molecular sciences, Vol. 20, Issue 1, (2019) (PubMed).
: "Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity." in: Developmental cell, Vol. 49, Issue 3, pp. 393-408.e7, (2019) (PubMed).
: "The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells." in: European review for medical and pharmacological sciences, Vol. 23, Issue 6, pp. 2681-2690, (2019) (PubMed).
Aliases for Baculoviral IAP Repeat-Containing 5 抗体
baculoviral IAP repeat containing 5 (BIRC5) 抗体baculoviral IAP repeat-containing 5 (Birc5) 抗体
baculoviral IAP repeat containing 5a (birc5a) 抗体
baculoviral IAP repeat-containing 5, gene 1 L homeolog (birc5.1.L) 抗体
baculoviral IAP repeat containing 5 L homeolog (birc5.2.L) 抗体
baculoviral IAP repeat containing 5b (birc5b) 抗体
baculoviral IAP repeat containing 5 S homeolog (birc5.2.S) 抗体
AAC-11 抗体
AP14 抗体
API4 抗体
Api4 抗体
api4 抗体
BIR1 抗体
bir1-A 抗体
bir5a 抗体
bir5b 抗体
birc5.2 抗体
birc5.2-a 抗体
birc5.2-b 抗体
EPR-1 抗体
epr-1 抗体
SIX 抗体
Su1 抗体
Su2 抗体
survivin 抗体
survivin40 抗体
svv1 抗体
svv2 抗体
TIAP 抗体
XBIR1 抗体
xsurv 抗体
xSurvivin 抗体
XSurvivin1 抗体
xSurvivin2 抗体
Xsvv1 抗体
